We are live on
!
Find out more
CCM
CrestPoint Capital Management Portfolio holdings
AUM
$180M
1-Year Est. Return
21.37%
This Fund
S&P 500
This Quarter
Est. Return
+4.46%
1 Year Est. Return
+21.37%
3 Year Est. Return
+42.59%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$200M
AUM Growth
+$4.29M
(+2.2%)
Cap. Flow
-$2.24M
Cap. Flow
% of AUM
-1.12%
Top 10 Holdings %
Top 10 Hldgs %
19.16%
Holding
237
New
20
Increased
41
Reduced
68
Closed
24
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Kinder Morgan
KMI
|
+$791K |
| 2 |
Pfizer
PFE
|
+$721K |
| 3 |
Colgate-Palmolive
CL
|
+$693K |
| 4 |
Walmart Inc
WMT
|
+$686K |
| 5 |
Centene
CNC
|
+$685K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
IM
Ingram Micro
IM
|
+$1.15M |
| 2 |
Cardinal Health
CAH
|
+$769K |
| 3 |
Entergy
ETR
|
+$714K |
| 4 |
VRNT
Verint Systems
VRNT
|
+$700K |
| 5 |
DNY
DONNELLEY R R & SONS CO
DNY
|
+$621K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 13.48% |
| 2 | Technology | 13.05% |
| 3 | Industrials | 13.05% |
| 4 | Healthcare | 12.27% |
| 5 | Consumer Discretionary | 8.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Synchrony
SYF
$24.7B
| – | – |
-11,000
| Closed | -$308K |
|
227
Universal Health Services
UHS
$10.2B
| – | – |
-2,000
| Closed | -$246K |
|
|
VRNT
228
DELISTED
Verint Systems
VRNT
| – | – |
-36,512
| Closed | -$700K |
|
229
NCR Voyix
VYX
$1.14B
| – | – |
-13,529
| Closed | -$267K |
|
230
World Kinect Corp
WKC
$2.04B
| – | – |
-9,300
| Closed | -$430K |
|
|
CERN
231
DELISTED
Cerner Corp
CERN
| – | – |
-6,700
| Closed | -$414K |
|
|
ALXN
232
DELISTED
Alexion Pharmaceuticals
ALXN
| – | – |
-2,400
| Closed | -$294K |
|
|
CLGX
233
DELISTED
Corelogic, Inc.
CLGX
| – | – |
-5,400
| Closed | -$212K |
|
|
HSNI
234
DELISTED
HSN, Inc.
HSNI
| – | – |
-5,300
| Closed | -$211K |
|
|
IM
235
DELISTED
Ingram Micro
IM
| – | – |
-32,300
| Closed | -$1.15M |
|
|
WR
236
DELISTED
Westar Energy Inc
WR
| – | – |
-4,800
| Closed | -$272K |
|
|
DNY
237
DELISTED
DONNELLEY R R & SONS CO
DNY
| – | – |
-39,500
| Closed | -$621K |
|
Similar funds
BIC
SMV
YP
EI
W
IA
WI
TCM
CrestPoint Capital Management's Q4 2016 Portfolio in Review
As of Q4 2016, CrestPoint Capital Management held 237 positions worth $200M, up 2.2% from $195M the previous quarter. Its ten largest holdings account for 19% of the portfolio.
CrestPoint Capital Management's Q4 2016 filing shows 20 new, 41 increased, 68 reduced and 24 closed positions. Its largest new stake was Kinder Morgan: 37,400 shares worth $775K. The largest sale was Ingram Micro, an estimated $1.15M.
By sector, the portfolio is most concentrated in Financials at 13% of assets, up from 12% a quarter earlier, followed by Technology and Industrials.
- CrestPoint Capital Management's largest Q4 2016 buy was Kinder Morgan: 37,400 shares worth $775K.
- CrestPoint Capital Management added most to Pfizer in Q4 2016, an estimated $721K increase.
- CrestPoint Capital Management's biggest Q4 2016 reduction was C.H. Robinson, cutting an estimated $593K.
- CrestPoint Capital Management fully exited Ingram Micro in Q4 2016, selling an estimated $1.15M.
- CrestPoint Capital Management's ten largest holdings make up 19% of its $200M portfolio in Q4 2016.
- CrestPoint Capital Management opened 20 new positions and closed 24 in Q4 2016.
- CrestPoint Capital Management's portfolio value rose 2.2% quarter-over-quarter to $200M.
Based on CrestPoint Capital Management's 13F filing for Q4 2016, filed 19 Jan 2017.